老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Armata Pharmaceuticals, Inc.

5.56
+0.39007.54%
成交量：9.43萬
成交額：51.89萬
市值：2.07億
市盈率：-1.05
高：5.70
開：5.23
低：5.23
收：5.17
52周最高：16.34
52周最低：2.40
股本：3,718.20萬
流通股本：1,187.54萬
量比：0.87
換手率：0.79%
股息：- -
股息率：- -
每股收益(TTM):-5.2744
每股收益(LYR):-4.8000
淨資產收益率：-3439.35%
總資產收益率：-25.83%
市淨率：-0.89
市盈率(LYR):-1.16

資料載入中...

總覽公司新聞資訊公告
2020/04/06

SEC問詢函

CORRESP [Cover] - Correspondence
2020/03/31

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/03/30

重要事件披露

Current report, items 3.02, 5.03, 5.07, 8.01, and 9.01
2020/03/19

重要事件披露

Current report, items 2.02 and 9.01
2020/03/19

重要事件披露

Current report, items 1.01, 7.01, and 9.01
2020/03/19

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/26

重要事件披露

Current report, items 5.03 and 9.01
2020/02/14

超過5%披露

General statement of acquisition of beneficial ownership
2020/02/13

重要事件披露

Current report, items 1.01, 3.02, 5.02, 8.01, and 9.01
2020/01/29

重要事件披露

Current report, items 1.01, 3.02, 8.01, and 9.01
2020/01/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/09

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2020/01/09

[補充]招股説明書

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/12/20

招股説明書

General form for registration of securities under the Securities Act of 1933
2019/12/11

重要事件披露

Current report, items 5.03, 5.07, and 9.01
2019/11/12

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/12

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/10/10

重要事件披露

Current report, items 5.02 and 9.01
2019/09/24

重要事件披露

Current report, items 7.01 and 9.01
2019/09/12

重要事件披露

Current report, items 8.01 and 9.01
更多